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1Applications of mass spectrometry to biological prob-
lems have increased substantially over the last decade
due primarily to the development of methods based on
MALDI and electrospray ionization. This book seeks to
provide the reader with a broad view of how mass
spectrometry is and has been utilized in the study of
cancer. Applications of mass spectrometry in cancer
epidemiology, diagnosis, treatment, and prevention are
described in detail. This book is intended for a large
audience, broadly defined as (1) mass spectroscopists
involved in cancer research or in providing core ser-
vices, (2) “customers”, i.e., researchers in the biological,
medical, pharmaceutical, or environmental sciences
who use mass spectrometry in their work, (3) potential
clients contemplating how to solve their intractable
analytical problems, and (4) academic and industrial
managers anxious to understand the approaches and
results of mass spectrometry being used in the projects
they direct or administer. Overall, this book succeeds in
reaching at least most of this vast audience. General
concepts of cancer biology and mass spectrometry are
defined and explained at a novice level when intro-
duced in the text. There are hundreds of references at
the end of each chapter. Mass Spectrometry to Cancer
Research is a valuable asset for any bioanalytical mass
spectrometrist, especially the beginning graduate stu-
dent.
The book is divided into six chapters. The first two
chapters are intended to familiarize the reader with
basic aspects of mass spectrometry. The third chapter is
intended to provide an overview of cancer biology. The
first three chapters are short (a total of 69 pages). The
last three chapters are concerned with applications of
mass spectrometry for the analysis of cancer biomarkers
(Chapter 4), chemopreventive agents (Chapter 5), and
specific compound classes (proteins, oligonucleotides,
carbohydrates, and lipids) where their chemistry is
pertinent to the development of neoplasia (Chapter 6).
The format of each sub-section in the last three chapters
is the same. First, the general structural features and
biological function of the molecule or compound class
of interest are summarized. The fragmentation charac-
teristics of a given compound class are described when
appropriate as well (e.g., proteins, oligonucleotides, and
carbohydrates). Next, the role of these compounds in
the development of tumors is discussed. Then several
examples of mass spectrometry analyses (with an em-
phasis on clinical applications) are presented.
The first chapter “Overview and Scope of Applica-
tions” defines some of the basic concepts associated
with the analytical chemistry of mass spectrometry
(precision, accuracy, limit of detection, and mass range)
and describes the function of the components of a mass
spectrometer (ion source, mass analyzer, and detector).
Most of the second chapter, “Instrumentation and Tech-
niques of Mass Spectrometry” explains different ioniza-
tion techniques, mass analyzers, and ion current detec-
tors. Several hybrid instruments and tandem MS
strategies for acquiring structural information are dis-
cussed as well. Of particular interest in this chapter are
the descriptions of capillary electrophoresis on a chip,
coupled to a Q-TOF through a nano-ESI emitter. Such
experimental strategies are being tested as a means of
analyzing very small quantities of biological fluids
directly by carrying out sample preparation (enzymatic
digestion, de-salting, etc.) on a chip in route to the mass
spectrometer.
Chapter 3, “Relevant Concepts of Cancer Biology
and Medicine” provides an excellent overview of how
this disease is classified, diagnosed, and treated. De-
spite the fact that all cancers share many common
characteristics (arise from mutant cells, evade normal
growth controls, colonize normal tissue), there are over
200 distinct types of cancer that are known. The mech-
anism of cancer cell proliferation and human immune
response are discussed at some length as well. The last
section of the chapter describes microbiological meth-
ods for the analysis of DNA and RNA damage and cell
proliferation.
Chapter 4, “Metabolism and Biomarkers of Carcino-
gens” is concerned with MS methods for the analysis of
molecules that are considered to be indicators of cancer
risk. A biomarker is defined as “an observable endpoint
that indicates events in the processes leading to dis-
ease”. The chapter explains various groupings and
classifications of carcinogens and the analysis of bi-
omarker molecules produced by carcinogen metabo-
lism. The MS studies described within the chapter are
based primarily on GC/MS. There is no discussion of
proteins as biomarkers; the focus is primarily on me-
tabolized carcinogens and to a lesser extent on carcin-
ogen-DNA adducts.
This chapter is generally well done, but not inclusive
of all carcinogen biomarkers. There is no mention of
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etc.) as carcinogens, a compound class to which there is
widespread human exposure, or some of NCI-GC/MS
assays that have been used to assay human exposure to
these compounds. The chemistry of DNA adducts that
form as a result of lipid peroxidation and their MS
analyses are omitted from this chapter as well.
Chapter 5, “Mechanism of Action and Metabolism of
Anti-Neoplastic and Chemopreventive Agents” de-
scribes mechanistic studies of a wide variety of anti-
cancer compounds that use MS as a key component.
This chapter is concerned with the chemistry and MS
analyses of four groups of compounds. These groups
include cytotoxic agents, hormones that inhibit tumor
growth, compounds designed for targeted drug deliv-
ery, and nutritional supplements. Most of the cytotoxic
agents section is concerned with the chemistry of alky-
lating agents that cross-link DNA helices in cancer cells
to prevent cell replication. The MS analyses of the
cytotoxic agents such as cis-platin and nitrogen mus-
tards (whose use as chemical warfare agents can be
traced back to World War I) are described. The MS
analyses of cytotoxic compounds that prevent tumor
growth by disrupting normal DNA synthesis, such as
5-fluorouracil, are discussed as well. The second group
of compounds treated are hormones that interfere with
tumor growth. The chemistry and analyses of tamoxifen
(a breast cancer drug) and its derivatives, are discussed
at length. Tamoxifen inhibits tumor growth by interfer-
ing with estrogen-dependent metabolic pathways. The
drug is also known to be tumorigenic in rats. Several
MS studies of the tamoxifen mechanism of tumor
control and initiation are described. The third section of
the chapter details MS studies of chemical agents that
promote site-specific drug delivery. Small molecule
anti-cancer agents are conjugated with carrier mole-
cules such as antibodies, lipids, or proteins that will
bind to the intended site of delivery. MS studies of these
conjugated molecules have been carried out with a
variety of ionization techniques (IR MALDI, ESI, FAB).
The last section of this chapter is concerned with the MS
analyses of nutritional supplements that are believed to
prevent cancer. Most of this section is concerned with
the chemistry of phytochemicals, plant-derived com-
pounds that occur in trace amounts. Many of these
compounds are sold as dietary supplements, and their
anti-cancer effects are controversial due to a lack of
rigorous scientific testing. The MS analyses of fla-
vanoids, a group of polyphenols found in many fruits
and vegetables, are discussed in great detail. Many of
the experimental methods described in this section are
based on multi-component analysis in complex mix-
tures such as garlic, wine, tea, and body fluids using
methods based on ESI LC/MS.
Chapter 6 is the longest chapter in the book (157
pages), “Strategies, Techniques, and Applications in
Cancer Biochemistry and Biology”. This chapter is
divided into four sections describing the MS analysis of
proteins, lipids, oligonucleotides, and carbohydrates
associated with cancer. More than three-quarters of the
chapter is devoted to proteins. The section on proteins
starts with a nice overview of proteomics and genomics
as areas of research. The section on proteins in cancer
describes a wide variety of cancer protein analyses,
most of which are based on laser desorption ionization.
Analytical methods based on surface-enhanced laser
desorption ionization (SELDI) are highlighted through-
out. A wealth of information regarding protein chem-
istry and analysis is presented here, but sometimes the
relevance to cancer is not obvious, particularly in the
section on protein–DNA interactions. The section on
lipids focuses on the analysis of ceramides, a class of
compounds that are incorporated into cell membranes
and function as intracellular messengers in cell signal-
ing pathways. The oligonucleotide section has a nice
description of how PCR methods are used in conjunc-
tion with mass spectrometry. Some elegant oligonucle-
otide recognition studies using DNA “chips” are de-
scribed also. The section on carbohydrates deals mainly
with protein glycosylation. A nice summary explana-
tion of glycoprotein structure and function is presented.
In summary, the book “Mass Spectrometry in Cancer
Research” is an invaluable resource for mass spectrom-
etrists (in particular). The text provides a myriad of
experimental applications and strategies for the MS
analyses of molecules that are central to the develop-
ment and prevention of cancer. All mass spectrom-
etrists who are interested in doing cancer research
should procure a copy.
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